Home Infusion Solutions, of Falmouth, 295 Main St., Falmouth was ordered to stop sterile compounding on Dec. 27 after problems with its facility and process came to light. This is one of many locations of Infusion Care A.K.A Home Solutions. It's website says Home Solutions, one of the largest independent home infusion providers in the country, is an industry leader.
The state has issued cease and desist letters to 11 pharmacies for a range of violations, and cited another 21 for minor deficiencies, since inspectors started making unannounced visits in the wake of a nationwide fungal meningitis outbreak that began at a Framingham compounding pharmacy.
"The disturbing results of these inspections, and the need for regulators to force the closure of all or part of 11 compounding pharmacies, are further evidence of another systemic failure of oversight by state government," said Senate Minority Leader Bruce Tarr in a statement. "If the current system tolerated this degree of regulatory noncompliance, then clearly, it's time for serious reform."
CDC: 696 infections and 45 deaths in 20 states
Beyond merely distributing medication, compounding pharmacies produce special batches of medication for individual patients. New England Compounding Center was allegedly using its compounding license to produce wholesale quantities of medications in violation of its license, and unsanitary conditions lead to the shipping of tainted steroids causing 696 infections and 45 deaths in 20 states, according to the Centers for Disease Control.
In the wake of that outbreak, the Board of Registration in Pharmacy started unannounced inspections on the state's 40 sterile compounding pharmacies, and has since ordered 11 pharmacies to close or shut down some of their operation, according to the Department of Public Health. Eight have since submitted corrective action plans.
The pharmacies are:
Apothecare, Baystate, Home Infusion Solutions, OncoMed, PalliMed, PharMerica, Western Mass and West River all submitted correction plans for review.